2003中华医学杂志:英文版Requires access

A combination of Ang II and carbon tetrachloride accelerates process of hepatic fibrosis

周馨, 李定国, 李宣海, 陆汉明, 张文竹

Open publisher page 0 citations

Abstract

Objective To assess whether Angiotensin Ⅱ (Ang Ⅱ) and carbon tetrachloride (CCl4) used in combination could accelerate the process of fibrosis and whether Ang Ⅱ play a role in exaggerating hepatic fibrosis in rats.Methods Ang Ⅱ was injected into the abdominal cavity of Sprague-Dawley (SD) rats together with subcutaneous injection of CCl4. Rats were killed after 14 and 28 d. Blood serum and liver specimen were collected. The extent of fibrosis in the stained liver tissue sections was determined with the KS 400 Image Analysis System. Results Rats receiving Ang Ⅱ and CCl4 for 28 d showed extensive liver fibrosis. Along with the increase of hepatic fibrosis, the serum concentration of Ang Ⅱ went up gradually. Conclusions A combination of Ang Ⅱ and CCl4 would accelerate the process of hepatic fibrosis. Ang Ⅱ probably took part in the occurrence of heparic fibrosis.

About this research paper

What this paper is about

Objective To assess whether Angiotensin Ⅱ (Ang Ⅱ) and carbon tetrachloride (CCl4) used in combination could accelerate the process of fibrosis and whether Ang Ⅱ play a role in exaggerating hepatic fibrosis in rats.Methods Ang Ⅱ was injected into the abdominal cavity of Sprague-Dawley (SD) rats together with subcutaneous injection of CCl4. Rats were killed after 14 and 28 d. Blood serum and liver specimen were collected. The extent of fibrosis in the stained liver tissue sections was determined with the KS 400 Image Analysis System. Results Rats receiving Ang Ⅱ and CCl4 for 28 d showed extensive liver fibrosis. Along with the increase of hepatic fibrosis, the serum concentration of Ang Ⅱ went up gradually. Conclusions A combination of Ang Ⅱ and CCl4 would accelerate the process of hepatic fibrosis. Ang Ⅱ probably took part in the occurrence of heparic fibrosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To assess whether Angiotensin Ⅱ (Ang Ⅱ) and carbon tetrachloride (CCl4) used in combination could accelerate the process of fibrosis and whether Ang Ⅱ play a role in exaggerating hepatic fibrosis in rats.Methods Ang Ⅱ was injected into the abdominal cavity of Sprague-Dawley (SD) rats together with subcutaneous injection of CCl4. Rats were killed after 14 and 28 d. Blood serum and liver specimen were collected. The extent of fibrosis in the stained liver tissue sections was determined with the KS 400 Image Analysis System. Results Rats receiving Ang Ⅱ and CCl4 for 28 d showed extensive liver fibrosis. Along with the increase of hepatic fibrosis, the serum concentration of Ang Ⅱ went up gradually. Conclusions A combination of Ang Ⅱ and CCl4 would accelerate the process of hepatic fibrosis. Ang Ⅱ probably took part in the occurrence of heparic fibrosis.

Key concepts: Carbon tetrachloride, Hepatic fibrosis, CCL4, Fibrosis, Abdominal cavity, Angiotensin II, Internal medicine, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
A combination of Ang II and carbon tetrachloride accelerates process of hepatic fibrosis — Research Paper | ScholarLens